MedTrace Logo

Exoskeleton-assisted Neurorehabilitation

NCT07352085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2026-01-20

No results posted yet for this study

Summary

* Objective assesment of the feasibility of integrating the Ekso Bionics - Ekso NR device into outpatient care
* Objective assesment of quality of life, functionality and clinical symptomps of patients with stroke, cerebellar ataxia, spinal cord injury, and spastic paraparesis
* Comparison of measured data and follow-up of changes in relation to themselves and each other
* Analyzing the effects of the exoskeleton among the patients
* Assessing the safety, possible side effects and tolerability of the EksoNR

Conditions

  • Stroke
  • Spinal Cord Injuries (Complete and Incomplete)
  • Cerebellar Ataxia
  • Spastic Paraplegia

Interventions

DEVICE

Gait training with exoskeleton

EksoNR is a wearable, battery-powered bionic exoskeleton that enables individuals with neurological or muscular injuries, lower limb weakness, paralysis, or gait disorders to stand and walk on flat surfaces. The hip and knee joints are powered by motors, and all movements are performed either by the patient's specific movements or by using an external controller. The robot's functions can be adjusted to determine the level of assistance the device provides to the patient.

Sponsors & Collaborators

  • Somogy Megyei Kaposi Mór Teaching Hospital

    lead OTHER

Principal Investigators

  • József Dr. habil. Tollár · Somogy County Kaposi Mór Teaching Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07352085 on ClinicalTrials.gov